| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Gregory F Oxenkru. Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging. Annals of the New York Academy of Sciences. vol 1122. 2008-04-21. PMID:18077563. |
vci is characterized by impairment of the executive function and is distinct from alzheimer's-type and multi-infarct dementias, although vci might overlap with alzheimer's disease. |
2008-04-21 |
2023-08-12 |
Not clear |
| L Bracco, V Bessi, C Piccini, L Mosconi, A Pupi, S Sorb. Metabolic correlates of executive dysfunction. Different patterns in mild and very mild Alzheimer's disease. Journal of neurology. vol 254. issue 8. 2008-02-01. PMID:17385079. |
this study was designed to examine the correlations between resting-state brain glucose metabolism (cmrglc), as measured with positron emission tomography and performance on executive function tasks in alzheimer's disease (ad), while taking into account the severity of cognitive deterioration. |
2008-02-01 |
2023-08-12 |
human |
| Naama Levy-Cooperman, Nancy J Lobaugh, Curtis Caldwell, FuQiang Gao, Sandra E Blac. Subcortical hyperintensities in Alzheimer's disease: no clear relationship with executive function and frontal perfusion on SPECT. Dementia and geriatric cognitive disorders. vol 24. issue 5. 2008-01-10. PMID:17934273. |
subcortical hyperintensities in alzheimer's disease: no clear relationship with executive function and frontal perfusion on spect. |
2008-01-10 |
2023-08-12 |
Not clear |
| Naama Levy-Cooperman, Nancy J Lobaugh, Curtis Caldwell, FuQiang Gao, Sandra E Blac. Subcortical hyperintensities in Alzheimer's disease: no clear relationship with executive function and frontal perfusion on SPECT. Dementia and geriatric cognitive disorders. vol 24. issue 5. 2008-01-10. PMID:17934273. |
to investigate relationships between subcortical hyperintensities (sh), frontal perfusion and executive function (ef) in a sample of alzheimer's disease (ad) patients with varying severities of sh. |
2008-01-10 |
2023-08-12 |
Not clear |
| Erik Scherder, Laura Eggermont, Joseph Sergeant, Froukje Boersm. Physical activity and cognition in Alzheimer's disease: relationship to vascular risk factors, executive functions and gait. Reviews in the neurosciences. vol 18. issue 2. 2007-07-20. PMID:17593877. |
physical activity and cognition in alzheimer's disease: relationship to vascular risk factors, executive functions and gait. |
2007-07-20 |
2023-08-12 |
Not clear |
| Andrew Kir. Target symptoms and outcome measures: cognition. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. vol 34 Suppl 1. 2007-06-13. PMID:17469681. |
the cognitive section of the alzheimer's disease assessment scale (adas-cog) remains the most widely used cognitive measure in dementia trials although it does not assess attention, executive function, or agnosia. |
2007-06-13 |
2023-08-12 |
Not clear |
| Scott D Moffat, Susan M Resnic. Long-term measures of free testosterone predict regional cerebral blood flow patterns in elderly men. Neurobiology of aging. vol 28. issue 6. 2007-05-17. PMID:16698125. |
we previously reported that high circulating free testosterone (t) was associated with better performance on tests of memory, executive function, and spatial ability, and with a reduced risk for alzheimer's disease. |
2007-05-17 |
2023-08-12 |
Not clear |
| Bruce R Reed, Dan M Mungas, Joel H Kramer, William Ellis, Harry V Vinters, Chris Zarow, William J Jagust, Helena C Chu. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. Brain : a journal of neurology. vol 130. issue Pt 3. 2007-04-16. PMID:17267522. |
consistent with this, neuropsychological studies of clinically diagnosed patients have reported that individuals with vascular dementia do better on memory tests and worse on executive function tests compared with patients with alzheimer's disease. |
2007-04-16 |
2023-08-12 |
human |
| Bruce R Reed, Dan M Mungas, Joel H Kramer, William Ellis, Harry V Vinters, Chris Zarow, William J Jagust, Helena C Chu. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease. Brain : a journal of neurology. vol 130. issue Pt 3. 2007-04-16. PMID:17267522. |
analysis of group data showed that for alzheimer's disease memory scores were lower than executive function by nearly a standard deviation on average. |
2007-04-16 |
2023-08-12 |
human |
| Pearl Behl, Christian Bocti, Richard H Swartz, FuQiang Gao, Demetrios J Sahlas, Krista L Lanctot, David L Streiner, Sandra E Blac. Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients. Archives of neurology. vol 64. issue 2. 2007-03-13. PMID:17296844. |
strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated alzheimer patients. |
2007-03-13 |
2023-08-12 |
Not clear |
| Audrey Duarte, Satoru Hayasaka, Antao Du, Norbert Schuff, Geon-Ho Jahng, Joel Kramer, Bruce Miller, Michael Weine. Volumetric correlates of memory and executive function in normal elderly, mild cognitive impairment and Alzheimer's disease. Neuroscience letters. vol 406. issue 1-2. 2006-11-03. PMID:16904823. |
volumetric correlates of memory and executive function in normal elderly, mild cognitive impairment and alzheimer's disease. |
2006-11-03 |
2023-08-12 |
Not clear |
| Werner Poewe, Erik Wolters, Murat Emre, Marco Onofrj, Chuanchieh Hsu, Sibel Tekin, Roger Lan. Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study. Movement disorders : official journal of the Movement Disorder Society. vol 21. issue 4. 2006-09-26. PMID:16229010. |
efficacy assessments included the alzheimer's disease assessment scale cognitive subscale (adas-cog) and other measures of cognition, daily function, neuropsychiatric symptoms, and executive function. |
2006-09-26 |
2023-08-12 |
Not clear |
| Joukje M Oosterman, Erik J A Scherde. Distinguishing between vascular dementia and Alzheimer's disease by means of the WAIS: a meta-analysis. Journal of clinical and experimental neuropsychology. vol 28. issue 7. 2006-09-19. PMID:16840242. |
we expected the alzheimer's disease group to outperform the vascular dementia group on those subtests that require executive functions, whereas inferior performance of the alzheimer's disease patients was expected on memory tests. |
2006-09-19 |
2023-08-12 |
Not clear |
| Joukje M Oosterman, Erik J A Scherde. Distinguishing between vascular dementia and Alzheimer's disease by means of the WAIS: a meta-analysis. Journal of clinical and experimental neuropsychology. vol 28. issue 7. 2006-09-19. PMID:16840242. |
secondly, a subcortical vascular dementia subgroup was distinguished and performance of this subgroup was compared to that of the alzheimer's disease group.overall, the analyses showed that both the vascular dementia and, more strongly, the subcortical vascular dementia group revealed decreased executive functions on several subtests compared to the alzheimer's disease group. |
2006-09-19 |
2023-08-12 |
Not clear |
| Armin von Gunten, Constantin Bouras, Enikö Kövari, Panteleimon Giannakopoulos, Patrick R Ho. Neural substrates of cognitive and behavioral deficits in atypical Alzheimer's disease. Brain research reviews. vol 51. issue 2. 2006-09-08. PMID:16413610. |
alzheimer's disease (ad) is a neurodegenerative disorder characterized by a progressive cognitive decline that typically affects first memory and later executive functions, language, and visuospatial skills. |
2006-09-08 |
2023-08-12 |
Not clear |
| P Behl, K L Lanctôt, D L Streiner, I Guimont, S E Blac. Cholinesterase inhibitors slow decline in executive functions, rather than memory, in Alzheimer's disease: a 1-year observational study in the Sunnybrook dementia cohort. Current Alzheimer research. vol 3. issue 2. 2006-07-28. PMID:16611015. |
cholinesterase inhibitors slow decline in executive functions, rather than memory, in alzheimer's disease: a 1-year observational study in the sunnybrook dementia cohort. |
2006-07-28 |
2023-08-12 |
Not clear |
| S Zaja-Milatovic, C D Keene, K S Montine, J B Leverenz, D Tsuang, T J Montin. Selective dendritic degeneration of medium spiny neurons in dementia with Lewy bodies. Neurology. vol 66. issue 10. 2006-06-28. PMID:16717229. |
dementia with lewy bodies (dlb) is the second most common form of dementia and shows more severely impaired performance on tests of executive functions compared to alzheimer disease. |
2006-06-28 |
2023-08-12 |
Not clear |
| Eric Ecklund-Johnson, Ivan Torre. Unawareness of deficits in Alzheimer's disease and other dementias: operational definitions and empirical findings. Neuropsychology review. vol 15. issue 3. 2006-04-12. PMID:16328733. |
empirical research examining this phenomenon has addressed a number of aspects of unawareness in alzheimer's disease and other dementias, including occurrence in various disorders; possible neuroanatomical substrates; relationship to general cognitive functioning, executive functioning, and psychiatric symptomatology; and progression over time and across cognitive domains. |
2006-04-12 |
2023-08-12 |
Not clear |
| Sophie Baudic, Gianfranco Dalla Barba, Marie Claude Thibaudet, Alain Smagghe, Philippe Remy, Latchezar Trayko. Executive function deficits in early Alzheimer's disease and their relations with episodic memory. Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists. vol 21. issue 1. 2006-04-11. PMID:16125364. |
executive function deficits in early alzheimer's disease and their relations with episodic memory. |
2006-04-11 |
2023-08-12 |
Not clear |
| Sophie Baudic, Gianfranco Dalla Barba, Marie Claude Thibaudet, Alain Smagghe, Philippe Remy, Latchezar Trayko. Executive function deficits in early Alzheimer's disease and their relations with episodic memory. Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists. vol 21. issue 1. 2006-04-11. PMID:16125364. |
previous research suggests that patients with alzheimer's disease (ad) are impaired on executive function early in the course of disease, but negative findings were reported. |
2006-04-11 |
2023-08-12 |
Not clear |